CRISPR Breakthrough Revives Chemo Response in Resistant Lung Tumors, Study Finds
WILMINGTON, DE — A new study from ChristianaCare’s Gene Editing Institute shows that disabling a single gene with CRISPR technology can restore chemotherapy sensitivity in lung cancer, a development researchers …
CRISPR Breakthrough Revives Chemo Response in Resistant Lung Tumors, Study Finds Read More